Product Pathways - Cytoskeletal Signaling
WAVE-3 Antibody #2806
|2806S||100 µl (10 western blots)||---||In Stock||---|
|2806||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse, Rat, Monkey||Endogenous||65-70||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Specificity / Sensitivity
WAVE-3 Antibody detects endogenous levels of total WAVE-3 protein. The antibody does not cross-react with WAVE-1 or WAVE-2.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to the central sequence of human WAVE-3. Antibodies are purified using protein A and peptide affinity chromatography.
Wiskott-Aldrich syndrome proteins (WASPs) mediate actin dynamics by activating the Arp2/3 actin nucleation complex in response to activated Rho family GTPases. In mammals, five WASP family members have been described. Hematopoietic WASP and ubiquitously expressed N-WASP are autoinhibited in unstimulated cells. Upon stimulation they are activated by cdc42, which relieves the autoinhibition in conjunction with phosphatidyl inositol 4,5-bisphosphate. Three WAVE (Wasf, SCAR) family proteins are similar in sequence to WASP and N-WASP but lack the WASP/N-WASP autoinhibition domains and are indirectly activated by Rac (reviewed in 1). Both WASP and WAVE functions appear to be essential, as knockout of either N-WASP or Scar-2 in mice results in cardiac and neuronal defects and embryonic lethality (2,3). Loss of WASP results in immune system defects and fewer immune cells (4). WAVE-2 (WASF2) is widely distributed, while WAVE-1 and WAVE-3 are strongly expressed in brain (5). WAVE-3 may act as a tumor suppressor in neuroblastoma, a childhood disease of the sympathetic nervous system (6). Increased expression of WAVE-3 is seen in breast cancer, and studies in breast adenocarcinoma cells indicate that WAVE-3 regulates breast cancer progression, invasion and metastasis through the p38 mitogen-activated protein kinase (MAPK) pathway (7,8).
- Millard, T.H. et al. (2004) Biochem J. 380, 1-17.
- Yan, C. et al. (2003) EMBO J. 22, 3602-3612.
- Snapper, S.B. et al. (2001) Nat. Cell Biol. 3, 897-904.
- Zhang, J. et al. (1999) J. Exp. Med. 190, 1329-4132.
- Suetsugu, S. et al. (1999) Biochem. Biophys. Res. Commun. 260, 296-302.
- Sossey-Alaoui, K. et al. (2002) Oncogene 21, 5967-5974.
- Sossey-Alaoui, K. et al. (2005) Exp. Cell Res. 308, 135-145.
- Sossey-Alaoui, K. et al. (2007) Am J Pathol 170, 2112-21.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.